Following early stage discovery, LSTM engages on various platforms to promote the development of new diagnostics; drugs; vaccines; public health pesticides and other tools.
Following early stage discovery, LSTM engages on various platforms to promote the development of new diagnostics; drugs; vaccines; public health pesticides and other tools by helping to define product gaps and market failures.
LSTM has growing expertise in developing clinical interventions to authoritatively evaluate new vaccines, drugs, diagnostics and pesticides within internationally accepted regulatory frameworks. LSTM also conducts relevant clinical research (i.e. field trials) that will contribute to new product pipelines and initiates industry partnerships which will bring these new products to market.